0075.KLSE Lyc Healthcare Bhd
- Market cap
- MYR 3.70M
- P/E
- -
- P/B
- 1.28x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- 0.9/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 0075.KLSE undervalued?
Graham numberThe Graham number of Lyc Healthcare Bhd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Lyc Healthcare Bhd fundamental analysis
3 of 21 checks passedROE 0/2
ROE cannot be calculated: equity is negative or not reported.
ROA 0/1
Return on assets (-6.4%) is below the industry median (1.1%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-29.8%) is below the industry median (13.6%).
Revenue Growth 2/2
Revenue grew 13.5% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 2/2
Loss-making but free cash flow is positive.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (1.3x) is above the industry median (0.9x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About Lyc Healthcare Bhd
LYC Healthcare Berhad provides health care services primarily in Malaysia and Singapore. The company operates through three segments: Healthcare Services, Computing and Electronic Services, and Other segments. It engages in the provision of mother and childcare related services, such as postnatal and postpartum care, post-delivery confinement care, and aesthetics; healthcare related services; cosmetics related and medical aesthetic treatment services; dental treatment and co…
Full company profileLyc Healthcare Bhd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Lyc Healthcare Bhd annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 41.2M | 6.41M | 7.60M | 12.4M | 26.4M | 64.6M | 92.3M | 130M | 156M | 135M | 136M |
| Gross Profit | 5.90M | 1.91M | 1.68M | 2.98M | 11.6M | 32.2M | 41.6M | 68.7M | 69.0M | 52.9M | 53.7M |
| Operating Income | -2.62M | -3.20M | -7.22M | -9.18M | -7.28M | 8.00M | 1.38M | -549K | 2.65M | -3.07M | 6.31M |
| EBITDA | - | -5.04M | -4.80M | -4.99M | -1.39M | 15.1M | 8.64M | 12.1M | 20.3M | 19.8M | 6.71M |
| Net Income | -1.99M | -5.18M | -5.93M | -9.70M | -11.9M | -9.23M | -19.2M | -19.2M | -17.1M | -22.9M | -12.7M |
| EPS | -0.01 | -0.02 | -0.02 | -0.03 | -0.03 | -0.02 | -0.03 | -0.03 | -0.02 | -0.03 | -0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 22.6M | 31.2M | 42.3M | 57.1M | 136M | 183M | 216M | 243M | 235M | 198M | 197M |
| Total Liabilities | 13.4M | 11.0M | 19.3M | 35.7M | 116M | 156M | 169M | 165M | 220M | 159M | 157M |
| Shareholders' Equity | 9.20M | 20.2M | 23.0M | 21.4M | 19.7M | 27.6M | 46.9M | 39.0M | 15.2M | -10.6M | -10.9M |
| Cash & Short-term Investments | 6.05M | 12.9M | 10.1M | 4.02M | 15.4M | 21.8M | 40.2M | 24.7M | 17.7M | 7.48M | 17.4M |
| Total Debt | 1.92M | 1.79M | 14.0M | 26.2M | 87.3M | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -2.57M | -2.40M | -4.28M | -1.47M | -1.78M | 344K | 15.6M | 9.15M | 28.7M | 28.5M | 12.7M |
| Capital Expenditure | 73.0K | 6.55M | 3.08M | 10.4M | 3.81M | 2.88M | 2.64M | 5.70M | 5.65M | 4.42M | 4.02M |
| Free Cash Flow | - | -8.96M | -7.36M | -11.8M | -5.61M | -2.54M | 2.46M | 3.45M | 15.4M | 24.1M | 8.65M |
| Ratios | |||||||||||
| ROE | -21.6% | -25.6% | -25.8% | -45.3% | -60.2% | -33.5% | -40.9% | -49.2% | -112.1% | - | - |
| ROA | -8.8% | -16.6% | -14.0% | -17.0% | -8.7% | -5.0% | -8.9% | -7.9% | -7.3% | -11.6% | -6.4% |
| Net Profit Margin | -4.8% | -80.8% | -78.0% | -78.0% | -44.9% | -14.3% | -20.8% | -14.7% | -11.0% | -17.0% | -9.3% |
| Debt to Equity | 0.21x | 0.09x | 0.61x | 1.22x | 4.43x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Lyc Healthcare Bhd dividends
Lyc Healthcare Bhd has not paid dividends in the last 9 fiscal years.
Who owns Lyc Healthcare Bhd
- Insiders 51.55%
- Institutions 20.09%
- Public & others 28.36%
- Shares outstanding 740M
- Free float 250M
Lyc Healthcare Bhd company profile
- Company name
- Lyc Healthcare Bhd
- Ticker
- 0075.KLSE
- ISIN
- MYQ0075OO000
- Exchange
- Kuala Lumpur Exchange
- Sector
- Technology
- Industry
- IT Services
- Employees
- 120
- Fiscal year end
- March
- Address
- Podium Block, Plaza VADS, Kuala Lumpur, Malaysia, 60000
- Phone
- 60 3 7733 9222
- Website
- lychealth.com
About Lyc Healthcare Bhd
LYC Healthcare Berhad provides health care services primarily in Malaysia and Singapore. The company operates through three segments: Healthcare Services, Computing and Electronic Services, and Other segments. It engages in the provision of mother and childcare related services, such as postnatal and postpartum care, post-delivery confinement care, and aesthetics; healthcare related services; cosmetics related and medical aesthetic treatment services; dental treatment and consultancy; child daycare; and medical and surgical advisory services, as well as deals in raw and finished, consumable and non-consumable food ingredients. The company also offers research and development; e-manufacturing solutions and IT outsourcing services; and computer and its related products. In addition, it provides business management consultant services; infrastructure for hosting and data processing services; general medical and prostate cancer treatment services; personal care, wellness, and promotion/management services; manufactures food and health supplements; senior nursing home care and related services; and other food products export and import services, as well as retailing various products over the internet. In addition, it manufactures, wholesales, and retails nutraceuticals, pharmaceutical, and healthcare products. The company was formerly known as Mexter Technology Berhad and changed its name to LYC Healthcare Berhad in January 2019. LYC Healthcare Berhad was founded in 1992 and is headquartered in Kuala Lumpur, Malaysia.
Lyc Healthcare Bhd management
8- Mr. Diong Hoe SuiMD, Group CEO & Executive Director · born 1955
- Ms. Ai Vi LeeChief Financial Officer · born 1978
- Ms. Yan Tong LimChief Investment Officer & COO of Confinement Centres · born 1995
- Ms. Siew Fong ChongHead of the ICT & Electronics Engineering Division · born 1969
- Mr. Hoo Hong SohChief Executive Officer of Project Management Division · born 1953
- Dr. Ying Ho ChanExecutive Director & MD of LYC Medicare Singapore Limited · born 1979
- Zhi Xuan LimCompany Secretary
- Mr. Wai Yi ChinCompany Secretary